CDEK
← All organizations

Antisoma Research

For profit
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

May 1, 2003

Last known activity

Jan 1, 2010

Defunct as of Oct 16, 2018

Timeline

1980s

  1. Jun 1, 1988

    Antisoma Research— Founded

2000s

  1. May 16, 2008

    Xanthus Pharmaceuticals, Inc.— Acquired

2010s

  1. Oct 16, 2018

    Antisoma Research— Defunct

Drugs by trial phase (10 distinct, 13 trials)

Phase 3 (1 own, 2 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (12)

Details

Founded
London, GB Jun 1, 1988
Last known activity
Jan 1, 2010